Inherent and benzo[a]pyrene-induced differential aryl hydrocarbon receptor signaling greatly affects life span, atherosclerosis, cardiac gene expression, and body and heart growth in mice

Toxicological Sciences

Volumn 126, Issue 2, 2012, Pages 391-404

  Kerley Hamilton, Joanna S ^a   Trask, Heidi W ^a   Ridley, Christian J A ^a,b   Dufour, Eric ^a   Lesseur, Corina ^a   Ringelberg, Carol S ^c   Moodie, Karen L ^a   Shipman, Samantha L ^a,d   Korc, Murray ^a,d   Gui, Jiang ^a,d   Shworak, Nicholas W ^a,d   Tomlinson, Craig R ^a,d  

^a NORRIS COTTON CANCER CENTER   (United States)

^b University of Bath   (United Kingdom)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Aryl hydrocarbon receptor; Atherosclerosis; Benzo a pyrene; Body and organ growth; Gene environment interactions; Western diet

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BODY GROWTH; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC CODE; GENOTYPE ENVIRONMENT INTERACTION; GROWTH RATE; HEART DEVELOPMENT; HEART SIZE; LETHALITY; LIFESPAN; MALE; MOUSE; NONHUMAN; QUALITATIVE ANALYSIS;

MUS;

EID: 84859097555     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs002     Document Type: Article

References (83)

1. Andreola, F., Fernandez-Salguero, P. M., Chiantore, M. V., Petkovich, M. P., Gonzalez, F. J., and De Luca, L. M. (1997). Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 57, 2835-2838.
2. Aragon, A. C., Kopf, P. G., Campen, M. J., Huwe, J. K., and Walker, M. K. (2008). In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: Effects on fetal and adult cardiac gene expression and adult cardiac and renal morphology. Toxicol. Sci. 101, 321-330.
3. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000). Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29.
4. Bond, J. A., Gown, A. M., Yang, H. L., Benditt, E. P., and Juchau, M. R. (1981). Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J. Toxicol. Environ. Health 7, 327-335.
5. Bond, J. A., Kocan, R. M., Benditt, E. P., and Juchau, M. R. (1979). Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured human fetal aortic smooth muscle cells. Life Sci. 25, 425-430.
6. Bond, J. A., Yang, H. Y., Majesky, M. W., Benditt, E. P., and Juchau, M. R. (1980). Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in chicken aortas: Monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitro. Toxicol. Appl. Pharmacol. 52, 323-335.
7. Brenner, D. A. (1996). New functions for the aryl hydrocarbon receptor. Hepatology 23, 379-380.
8. Breslow, J. L. (1996). Mouse models of atherosclerosis. Science 272, 685-688.
9. Curfs, D. M., Lutgens, E., Gijbels, M. J., Kockx, M. M., Daemen, M. J., and van Schooten, F. J. (2004). Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am. J. Pathol. 164, 101-108.
10. Dalton, T. P., Kerzee, J. K., Wang, B., Miller, M., Dieter, M. Z., Lorenz, J. N., Shertzer, H. G., Nerbert, D. W., and Puga, A. (2001). Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc. Toxicol. 1, 285-298.
11. Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., and Fujii-Kuriyama, Y. (1994). Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J. Biol. Chem. 269, 27337-27343.
12. Fedorowicz, G., Guerrero, S., Wu, T. D., and Modrusan, Z. (2009). Microarray analysis of RNA extracted from formalin-fixed, paraffinembedded and matched fresh-frozen ovarian adenocarcinomas. BMC Med. Genomics 2, 23.
13. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268, 722-726.
14. Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1996). Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140, 173-179.
15. Fernandez-Salguero, P. M., Ward, J. M., Sundberg, J. P., and Gonzalez, F. J. (1997). Lesions of aryl-hydrocarbon receptor-deficient mice. Vet. Pathol. 34, 605-614.
16. Galván, N., Jaskula-Sztul, R., MacWilliams, P. S., Czuprynski, C. J., and Jefcoate, C. R. (2003). Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver. Toxicol. Appl. Pharmacol. 193, 84-96.
17. Gonzalez, F. J., Tukey, R. H., and Nebert, D. W. (1984). Structural gene products of the Ah locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene. Mol. Pharmacol. 26, 117-121.
18. Guo, J., Sartor, M., Karyala, S., Medvedovic, M., Kann, S., Puga, A., Ryan, P., and Tomlinson, C. R. (2004). Expression of genes in the TGF-beta signaling pathway is significantly deregulated in smooth muscle cells from aorta of aryl hydrocarbon receptor knockout mice. Toxicol. Appl. Pharmacol. 194, 79-89.
19. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
20. Harper, P. A., Wong, J. Y., Lam, M. S., and Okey, A. B. (2002). Polymorphisms in the human AH receptor. Chem. Biol. Interact. 141, 161-187.
21. Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252, 954-958.
22. Hofstetter, J. R., Svihla-Jones, D. A., and Mayeda, A. R. (2007). A QTL on mouse chromosome 12 for the genetic variance in free-running circadian period between inbred strains of mice. J. Circadian Rhythms 5, 7.
23. Houweling, A. C., van Borren, M. M., Moorman, A. F. M., and Christoffels, V. M. (2005). Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. Cardiovasc. Res. 67, 583-593.
24. Iwano, S., Asanuma, F., Nukaya, M., Saito, T., and Kamataki, T. (2005a). CYP1A1-mediated mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 337, 708-712.
25. Iwano, S., Nukaya, M., Saito, T., Asanuma, F., and Kamataki, T. (2005b). A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 335, 220-226.
26. Juchau, M. R., Bond, J. A., and Benditt, E. P. (1976). Aryl 4-monooxygenase and cytochrome P-450 in the aorta: Possible role in atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 73, 3723-3725.
27. Karyala, S., Guo, J., Sartor, M., Medvedovic, M., Kann, S., Puga, A., Ryan, P., and Tomlinson, C. R. (2004). Different global gene expression profiles in benzo[a]pyrene- and dioxin-treated vascular smooth muscle cells of AHRknockout and wild-type mice. Cardiovasc. Toxicol. 4, 47-73.
28. Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., and Bradfield, C. A. (2000). Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 97, 10442-10447.
29. Legraverend, C., Guenthner, T. M., and Nebert, D. W. (1984). Importance of the route of administration for genetic differences in benzo[a]pyrene-induced in utero toxicity and teratogenicity. Teratology 29, 35-47.
30. Liu, S., Abdelrahim, M., Khan, S., Ariazi, E., Jordan, V. C., and Safe, S. (2006). Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. Biol. Chem. 387, 1209-1213.
31. McMillan, B. J., and Bradfield, C. A. (2007). The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proc. Natl. Acad. Sci. U.S.A. 104, 1412-1417.
32. Miller, K. P., and Ramos, K. S. (2001). Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons. Drug Metab. Rev. 33, 1-35.
33. Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., et al. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2, 645-654.
34. Moorthy, B., Miller, K. P., Jiang, W., and Ramos, K. S. (2002). The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: Role of cytochrome P4501B1. Cardiovasc. Res. 53, 1002-1009.
35. Moorthy, B., Miller, K. P., Jiang, W., Williams, E. S., Kondraganti, S. R., and Ramos, K. S. (2003). Role of cytochrome P4501B1 in benzo[a]pyrene bioactivation to DNA-binding metabolites in mouse vascular smooth muscle cells: Evidence from 32P-postlabeling for formation of 3-hydroxybenzo[a]-pyrene and benzo[a]pyrene-3,6-quinone as major proximate genotoxic intermediates. J. Pharmacol. Exp. Ther. 305, 394-401.
36. Najai, A. U., Larsen, M. C., Bushkofsky, J. R., Czuprynski, C. J., and Jefcoate, C. R. (2011). Acute disruption of bone marrow hematopoiesis by benzo(a)pyrene is selectively reversed by aryl hydrocarbon receptormediated processes. Mol. Pharmacol. 79, 724-734.
37. Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., and Ross, R. (1994). ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14, 133-140.
38. Nebert, D. W. (1989). The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20, 153-174.
39. Nebert, D. W., Jensen, N. M., Levitt, R. C., and Felton, J. S. (1980). Toxic chemical depression of the bone marrow and possible aplastic anemia explainable on a genetic basis. Clin. Toxicol. 16, 99-122.
40. Nebert, D. W., and Karp, C. L. (2008). Endogenous functions of the aryl hydrocarbon receptor (AHR): Intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. J. Biol. Chem. 283, 36061-36065.
41. Nebert, D. W., Levitt, R. C., Jensen, N. M., Lambert, G. H., and Felton, J. S. (1977). Birth defects and aplastic anemia: Differences in polycyclic hydrocarbon toxicity associated with the Ah locus. Arch. Toxicol. 39, 109-132.
42. Nebert, D. W., Puga, A., and Vasiliou, V. (1993). Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N. Y. Acad. Sci. 685, 624-640.
43. Nebert, D. W., Winker, J., and Gelboin, H. V. (1969). Aryl hydrocarbon hydroxylase activity in human placenta from cigarette smoking and nonsmoking women. Cancer Res. 29, 1763-1769.
44. Nukaya, M., Takahashi, Y., Gonzalez, F. J., and Kamataki, T. (2004). Aryl hydrocarbon receptor-mediated suppression of GH receptor and Janus kinase 2 expression in mice. FEBS Lett. 558, 96-100.
45. Nunnari, J. J., Zand, T., Joris, I., and Majno, G. (1989). Quantitation of oil red O staining of the aorta in hypercholesterolemic rats. Exp. Mol. Pathol. 51, 1-8.
46. Oesterling, E., Toborek, M., and Hennig, B. (2008). Benzo[a]pyrene induces intercellular adhesion molecule-1 through a caveolae and aryl hydrocarbon receptor mediated pathway. Toxicol. Appl. Pharmacol. 232, 309-316.
47. Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., et al. (2003). Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423, 545-550.
48. Oshima, M., Endoh, M., Endo, T. A., Toyoda, T., Nakajima-Takagi, Y., Sugiyama, F., Koseki, H., Kyba, M., Iwama, A., and Osawa, M. (2011). Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells. Blood 117, e142-e150.
49. Owens, G. K., Kumar, M. S., and Wamhoff, B. R. (2004). Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801.
50. Paigen, B., Morrow, A., Holmes, P. A.,Mitchell, D., and Williams, R. A. (1987). Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231-240.
51. Peeters, A., Barendregt, J. J., Willekens, F., Mackenbach, J. P., Al Mamun, A., and Bonneux, L. (2003). Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann. Intern. Med. 138, 24-32.
52. Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., and Maeda, N. (1992). Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 89, 4471-4475.
53. Pipes, G. C. T., Creemers, E. E., and Olson, E. N. (2006). The myocardin family of transcriptional coactivators: Versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 20, 1545-1556.
54. Pirooznia, M., Nagarajan, V., and Deng, Y. (2007). GeneVenn-A web application for comparing gene lists using Venn diagrams. Bioinformation 1, 420-422.
55. Poland, A., and Glover, E. (1980). 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Segregation of toxicity with the Ah locus. Mol. Pharmacol. 17, 86-94.
56. Poland, A., Palen, D., and Glover, E. (1994). Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 46, 915-921.
57. Puga, A., Tomlinson, C. R., and Xia, Y. (2005). Ah receptor signals cross-talk with multiple developmental pathways. Biochem. Pharmacol. 69, 199-207.
58. Ramos, K. S., and Parrish, A. R. (1995). Growth-related signaling as a target of toxic insult in vascular smooth muscle cells: Implications in atherogenesis. Life Sci. 57, 627-635.
59. Robinson, J. R., Felton, J. S., Levitt, R. C., Thorgeirsson, S. S., and Nebert, D. W. (1975). Relationship between "aromatic hydrocarbon responsiveness" and the survival times in mice treated with various drugs and environmental compounds. Mol. Pharmacol. 11, 850-865.
60. Sauzeau, V., Carvajal-Gonzalez, J. M., Riolobos, A. S., Sevilla, M. A., Menacho-Marquez, M., Roman, Ã.C., Abad, A., Montero, M. J., Fernandez-Salguero, P., and Bustelo, X. R. (2011). Transcriptional factor aryl hydrocarbon receptor (Ahr) controls cardiovascular and respiratory functions by regulating the expression of the Vav3 proto-oncogene. J. Biol. Chem. 286, 2896-2909.
61. Sayer, J. M., Whalen, D. L., and Jerina, D. M. (1989). Chemical strategies for the inactivation of bay-region diol epoxides, ultimate carcinogens derived from polycyclic aromatic hydrocarbons. Drug Metab. Rev. 20, 155-182.
62. Schlezinger, J. J., Liu, D., Farago, M., Seldin, D. C., Belguise, K., Sonenshein, G. E., and Sherr, D. H. (2006). A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol. Chem. 387, 1175-1187.
63. Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., and Bradfield, C. A. (1996). Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc. Natl. Acad. Sci. U.S.A. 93, 6731-6736.
64. Schwanekamp, J. A., Sartor, M. A., Karyala, S., Halbleib, D., Medvedovic, M., and Tomlinson, C. R. (2006). Genome-wide analyses show that nuclear and cytoplasmic RNA levels are differentially affected by dioxin. Biochim. Biophys. Acta 1759, 388-402.
65. Song, Y., Sonawane, N. D., Salinas, D., Qian, L., Pedemonte, N., Galietta, L. J., and Verkman, A. S. (2004). Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J. Biol. Chem. 279, 40629-40633.
66. St Clair, R. W. (1983). Metabolic changes in the arterial wall associated with atherosclerosis in the pigeon. Fed. Proc. 42, 2480-2485.
67. Sun, Y. V., Boverhof, D. R., Burgoon, L. D., Fielden, M. R., and Zacharewski, T. R. (2004). Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res. 32, 4512-4523.
68. Tabibiazar, R., Wagner, R. A., Ashley, E. A., King, J. Y., Ferrara, R., Spin, J. M., Sanan, D. A., Narasimhan, B., Tibshirani, R., Tsao, P. S., et al. (2005a). Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol. Genomics 22, 213-226.
69. Tabibiazar, R., Wagner, R. A., Spin, J. M., Ashley, E. A., Narasimhan, B., Rubin, E. M., Efron, B., Tsao, P. S., Tibshirani, R., and Quertermous, T. (2005b). Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 302-308.
70. Thackaberry, E. A., Jiang, Z., Johnson, C. D., Ramos, K. S., and Walker, M. K. (2005). Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: Modulation of cell cycle and extracellular matrix genes. Toxicol. Sci. 88, 231-241.
71. Thomas, R. S., Penn, S. G., Holden, K., Bradfield, C. A., and Rank, D. R. (2002). Sequence variation and phylogenetic history of the mouse Ahr gene. Pharmacogenetics 12, 151-163.
72. Uno, S., Dalton, T. P., Derkenne, S., Curran, C. P., Miller, M. L., Shertzer, H. G., and Nebert, D. W. (2004). Oral exposure to benzo[a]pyrene in the mouse: Detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol. Pharmacol. 65, 1225-1237.
73. Van den Berg, M., Birnbaum, L. S., Denison, M., De Vito, M., Farland, W., Feeley, M., Fiedler, H., Hakansson, H., Hanberg, A., Haws, L., et al. (2006). The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 93, 223-241.
74. Wang, Y., Zhu, W., and Levy, D. E. (2006). Nuclear and cytoplasmic mRNA quantification by SYBR Green based real-time RT-PCR. Methods 39, 356-362.
75. Watanabe, J., Shimada, T., Gillam, E. M., Ikuta, T., Suemasu, K., Higashi, Y., Gotoh, O., and Kawajiri, K. (2000). Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics 10, 25-33.
76. Weinshilboum, R. (2003). Inheritance and drug response. N. Engl. J. Med. 348, 529-537.
77. Whitlock, J. P., Jr (1993). Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6, 754-763.
78. Williams, J. A., and Phillips, D. H. (2000). Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res. 60, 4667-4677.
79. Wong, J. M., Okey, A. B., and Harper, P. A. (2001). Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem. Biophys. Res. Commun. 288, 990-996.
80. Wu, D., Nishimura, N., Kuo, V., Fiehn, O., Shahbaz, S., Van Winkle, L., Matsumura, F., and Vogel, C. (2011). Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E-/- mice. Arterioscler. Thromb. Vasc. Biol. 31, 1260-1267.
81. Zeiher, B. G., Eichwald, E., Zabner, J., Smith, J. J., Puga, A. P., McCray, P. B., Jr, Capecchi, M. R., Welsh, M. J., and Thomas, K. R. (1995). A mouse model for the delta F508 allele of cystic fibrosis. J. Clin. Investig. 96, 2051-2064.
82. Zhang, S., Lei, P., Liu, X., Li, X., Walker, K., Kotha, L., Rowlands, C., and Safe, S. (2009). The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy. Endocr. Relat. Cancer 16, 835-844.
83. Zhou, Y., Jiang, L., and Rui, L. (2009). Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J. Biol. Chem. 284, 11152-11159.